Skip to main content
Eikon Therapeutics, Inc. (EIKN)
NASDAQ: EIKN · Real-Time Price · USD
5.98
-0.06 (-0.99%)
Nov 13, 2026, 4:00 PM EST - Market closed

Eikon Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
Market Capitalization
324---
Market Cap Growth
----
Enterprise Value
112---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.650.910.860.07
Net Debt / Equity Ratio
-0.55-0.28-0.07-0.85
Net Debt / EBITDA Ratio
0.640.270.071.57
Net Debt / FCF Ratio
0.800.330.081.82
Quick Ratio
6.976.113.9013.69
Current Ratio
7.216.344.0413.88
Return on Equity (ROE)
-90.94%-125.02%-69.35%-
Return on Assets (ROA)
-32.84%-36.19%-32.00%-
Return on Capital Employed (ROCE)
-55.40%-58.30%-59.90%-53.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23
Buyback Yield / Dilution
-1194.24%-14.85%-24.35%-
SEC Filings: 10-K · 10-Q